Antisense Oligonucleotides Specific for the HER2/neu Oncogene Inhibit the Growth of Human Breast Carcinoma Cells That Overexpress HER2/neu

By Roh H.   Pippin J.   Boswell C.   Drebin J.A.  

Journal of Surgical Research, Vol. 77, Iss. 1, 1998-06 ,pp. : 85-90

Academic Press

Access to resources Recommend Favorite

Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique

By Nathanson D.R.   Nash G.M.   Chen B.   Gerald W.   Paty P.B.  

Journal of the American College of Surgeons, Vol. 197, Iss. 3, 2003-09 ,pp. : 419-425

Elsevier

Access to resources Recommend Favorite

HER-2/neu overexpression is an independent prognostic factor in colorectal cancer

By Park Dong   Kang Mun   Oh Suk   Kim Hong   Cho Yong   Sohn Chong   Jeon Woo   Kim Byung   Han Won   Kim Hungdai   Ryu Seung   Sepulveda Antonia  

International Journal of Colorectal Disease, Vol. 22, Iss. 5, 2007-05 ,pp. : 491-497

Springer Publishing Company

Access to resources Recommend Favorite

Combining the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, ZD1839, with a selective cyclooxygenase (COX)-2 inhibitor, SC236, causes a cooperative antitumor effect in breast cancer cells derived from HER2/neu mice

By Rosato F.E.   Dicker A.   Burd R.   Miller S.   Lanza-Jacoby S.  

Journal of Surgical Research, Vol. 114, Iss. 2, 2003-10 ,pp. : 274-274

Elsevier

Access to resources Recommend Favorite

Cox-2 and Her2/neu expression in bladder cancer: Correlation with clinicopathological data and long-term follow-up

By Wulfing C.   Eltze E.   Von Struensee D.   Wulfing P.   Boecker W.   Hertle L.   Piechota H.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 43-43

Elsevier

Access to resources Recommend Favorite